<Media xmlns:cdr="cips.nci.nih.gov/cdr">
 
 <MediaTitle>skalet table 1 retinoblastoma</MediaTitle>
 <PhysicalMedia>
  <ImageData>
   <ImageType>photo</ImageType>
   <ImageEncoding>JPEG</ImageEncoding>
   <Color>BW</Color>
   <Labeled>Yes</Labeled>
   <LabelName language="en">Table 1. Pretest Risk for Relatives to Carry the Mutant RB1 Allele of the Proband</LabelName><LabelName language="en">Relative of Proband</LabelName><LabelName language="en">Relative of Proband	Pretest Risk for Mutant Allele (%)</LabelName><LabelName language="en">	Bilateral Proband (100)	Unilateral Proband (15)</LabelName><LabelName language="en">Unilateral Proband (15)</LabelName><LabelName language="en">Offspring (infant)	50	7.5</LabelName><LabelName language="en">50</LabelName><LabelName language="en">7.5</LabelName><LabelName language="en">Parent</LabelName><LabelName language="en">5</LabelName><LabelName language="en">0.8</LabelName><LabelName language="en">Sibling</LabelName><LabelName language="en">2.5</LabelName><LabelName language="en">0.4</LabelName><LabelName language="en">Niece/nephew</LabelName><LabelName language="en">1.3</LabelName><LabelName language="en">0.2</LabelName><LabelName language="en">Aunt/uncle</LabelName><LabelName language="en">0.1</LabelName><LabelName language="en">0.007*</LabelName><LabelName language="en">First cousin</LabelName><LabelName language="en">0.05</LabelName><LabelName language="en">0.007*</LabelName><LabelName language="en">General population</LabelName><LabelName language="en">0.007</LabelName><LabelName language="en">Pretest risk for RB1 mutation in family members of an affected child with retinoblastoma. Risk for RB1 mutant allele is shown as a percentage for unilateral and bilateral probands without family history of retinoblastoma.</LabelName><LabelName language="en">*Third- and fourth-degree relatives of unilateral probands have calculated risks of 0.003% and 0.001%, respectively, which are less than the normal population risk of 0.007% (1 in 15 000 live births); therefore, the risk is stated at 0.007%.</LabelName><ImageDimensions>
    <HeightPixels>1028</HeightPixels>
    <WidthPixels>1502</WidthPixels>
   </ImageDimensions>
  </ImageData>
 </PhysicalMedia>
 <MediaSource>
  <OriginalSource>
   <Creator>Ophthalmology</Creator>
   <SourcePublication>Ophthalmology, Volume 125, Issue 3, Alison H. Skalet, Dan S. Gombos, Brenda L. Gallie, Jonathan W. Kim, Carol L. Shields, Brian P. Marr, Sharon E. Plon, Patricia Chévez-Barrios, Screening Children at Risk for Retinoblastoma: Consensus Report from the American Association of Ophthalmic Oncologists and Pathologists, Pages 453–458, Copyright (2018) Elsevier</SourcePublication><DateCreated>2019-11-06</DateCreated>
   <SourceFilename>Skalet Table 1 Retinoblastoma 11-6-19.jpg</SourceFilename>
  </OriginalSource>
 </MediaSource>
 <PermissionInformation>
    <PermissionRequested>Yes</PermissionRequested>
    <PermissionRequestDate>2019-10-10</PermissionRequestDate>
    <PermissionResponse>Permission Granted</PermissionResponse>
    <PermissionResponseDate>2019-10-10</PermissionResponseDate>
    
    <PublisherPermissionText>Pretest risk for relatives to carry the mutant RB1 allele of the proband. Reprinted from Ophthalmology, Volume 125, Issue 3, Alison H. Skalet, Dan S. Gombos, Brenda L. Gallie, Jonathan W. Kim, Carol L. Shields, Brian P. Marr, Sharon E. Plon, Patricia Chévez-Barrios, Screening Children at Risk for Retinoblastoma: Consensus Report from the American Association of Ophthalmic Oncologists and Pathologists, Pages 453–458, Copyright (2018), with permission from Elsevier.</PublisherPermissionText>
    <ApprovedUse>
     <Summary cdr:ref="CDR0000062846">Retinoblastoma Treatment</Summary>
     
    </ApprovedUse>
    <SpanishTranslationPermissionRequested>Yes</SpanishTranslationPermissionRequested>
    <SpanishTranslationPermissionResponse>Permission Granted</SpanishTranslationPermissionResponse>
    </PermissionInformation><MediaContent>
  <Categories>
   <Category>measurement</Category>
  </Categories>
  <Diagnoses>
   <Diagnosis cdr:ref="CDR0000043733">retinoblastoma</Diagnosis>
  </Diagnoses>
  
  <ContentDescriptions>
   <ContentDescription audience="Health_professionals" language="en">Table showing pretest risk for relatives to carry the mutant RB1 allele of the proband.</ContentDescription>
  </ContentDescriptions>
  <Captions>
   <MediaCaption audience="Health_professionals" language="en">Pretest risk for relatives to carry the mutant RB1 allele of the proband. Reprinted from Ophthalmology, Volume 125, Issue 3, Alison H. Skalet, Dan S. Gombos, Brenda L. Gallie, Jonathan W. Kim, Carol L. Shields, Brian P. Marr, Sharon E. Plon, Patricia Chévez-Barrios, Screening Children at Risk for Retinoblastoma: Consensus Report from the American Association of Ophthalmic Oncologists and Pathologists, Pages 453–458, Copyright (2018), with permission from Elsevier.</MediaCaption>
  </Captions>
 </MediaContent>
 <ProposedUse>
  <Summary cdr:ref="CDR0000062846">Retinoblastoma Treatment</Summary>
  
 </ProposedUse>
 <ProcessingStatuses><ProcessingStatus>
        <ProcessingStatusValue>Ready for Publishing</ProcessingStatusValue>
        <ProcessingStatusDate>2019-11-06</ProcessingStatusDate>
        <EnteredBy>yousufzaimg</EnteredBy>
        
       </ProcessingStatus>
  <ProcessingStatus>
   <ProcessingStatusValue>Caption and content approved</ProcessingStatusValue>
   <ProcessingStatusDate>2019-11-06</ProcessingStatusDate>
   <EnteredBy>yousufzaimg</EnteredBy>
   
  </ProcessingStatus>
 </ProcessingStatuses>
<RelatedDocuments>
         <SupplementaryInfoLink cdr:ref="CDR0000799897">Skalet_Table and Figure_Copyright&amp;Permissions_2019-10-31</SupplementaryInfoLink>
       </RelatedDocuments></Media>